Search - tctmd.com

Displaying 501 - 520 of 952

Sort: Relevancy | Date

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Oral Sirolimus Appears to Augment Efficacy of BMS

Caitlin E. Cox

August 23, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

L.A. McKeown

August 19, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

Performance of Bioabsorbable Scaffold Can Be Tracked with Noninvasive CT

August 08, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

Caitlin E. Cox

August 05, 2013

Advertisement

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Oral Sirolimus Appears to Augment Efficacy of BMS

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

Contemporary ZES Perform Well in Treating In-Stent Restenosis

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

Performance of Bioabsorbable Scaffold Can Be Tracked with Noninvasive CT

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content